{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:38:16Z","timestamp":1794436696287,"version":"4.9.1"},"reference-count":202,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7252174"],"award-info":[{"award-number":["7252174"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2024-13-59"],"award-info":[{"award-number":["320.6750.2024-13-59"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.pharmthera.2026.108991","type":"journal-article","created":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T22:44:56Z","timestamp":1769985896000},"page":"108991","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Pharmacological activation of cGAS-STING pathway to reverse cancer drug resistance"],"prefix":"10.1016","volume":"280","author":[{"given":"Yumin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingzhu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonglin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe-Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongquan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2026.108991_bb0005","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nature12306","article-title":"cGAS produces a 2'-5'-linked cyclic dinucleotide second messenger that activates STING","volume":"498","author":"Ablasser","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0010","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1039\/D1NR06577G","article-title":"Dual agonist immunostimulatory nanoparticles combine with PD1 blockade for curative neoadjuvant immunotherapy of aggressive cancers","volume":"14","author":"Atukorale","year":"2022","journal-title":"Nanoscale"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0015","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.molmed.2019.02.007","article-title":"Pharmacological modulation of the sting pathway for cancer immunotherapy","volume":"25","author":"Berger","year":"2019","journal-title":"Trends in Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0020","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.177523","article-title":"TTK inhibitor OSU13 promotes immunotherapy responses by activating tumor STING","volume":"9","author":"Bharti","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0025","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41573-020-00108-x","article-title":"Epigenetics and beyond: targeting writers of protein lysine methylation to treat disease","volume":"20","author":"Bhat","year":"2021","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0030","doi-asserted-by":"crossref","first-page":"7195","DOI":"10.1038\/s41467-025-62307-7","article-title":"DDX41 resolves G-quadruplexes to maintain erythroid genome integrity and prevent cGAS-mediated cell death","volume":"16","author":"Bi","year":"2025","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0035","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jmii.2020.07.010","article-title":"Loss of HPV type 16 E7 restores cGAS-STING responses in human papilloma virus-positive oropharyngeal squamous cell carcinomas cells","volume":"54","author":"Bortnik","year":"2021","journal-title":"Journal of Microbiology, Immunology, and Infection"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0040","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41573-019-0044-1","article-title":"The great escape: tumour cell plasticity in resistance to targeted therapy","volume":"19","author":"Boumahdi","year":"2020","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0045","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nature10429","article-title":"STING is a direct innate immune sensor of cyclic di-GMP","volume":"478","author":"Burdette","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0050","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1002\/mc.23753","article-title":"JMJD2A promotes the development of castration-resistant prostate cancer by activating androgen receptor enhancer and inhibiting the cGAS-STING pathway","volume":"63","author":"Cai","year":"2024","journal-title":"Molecular Carcinogenesis"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0055","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.7150\/ijbs.85236","article-title":"Activation of STING by SAMHD1 deficiency promotes PANoptosis and enhances efficacy of PD-L1 blockade in diffuse large B-cell lymphoma","volume":"19","author":"Cai","year":"2023","journal-title":"International Journal of Biological Sciences"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0060","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41419-025-07964-8","article-title":"CAD hijacks STING to impair antitumor immunity and radiotherapy efficacy of colorectal cancer","volume":"16","author":"Cai","year":"2025","journal-title":"Cell Death & Disease"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0065","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1158\/0008-5472.CAN-21-0628","article-title":"PBRM1 deficiency confers synthetic lethality to DNA repair inhibitors in cancer","volume":"81","author":"Chabanon","year":"2021","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0070","article-title":"CFI-402257, a TTK inhibitor, effectively suppresses hepatocellular carcinoma","volume":"119","author":"Chan","year":"2022","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0075","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.cmet.2023.07.009","article-title":"NSUN2 is a glucose sensor suppressing cGAS\/STING to maintain tumorigenesis and immunotherapy resistance","volume":"35","author":"Chen","year":"2023","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0080","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1038\/s41467-023-40312-y","article-title":"Chemically programmed STING-activating nano-liposomal vesicles improve anticancer immunity","volume":"14","author":"Chen","year":"2023","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0085","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1038\/s41467-023-38784-z","article-title":"TRABID inhibition activates cGAS\/STING-mediated anti-tumor immunity through mitosis and autophagy dysregulation","volume":"14","author":"Chen","year":"2023","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0090","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1186\/s12885-023-11343-x","article-title":"TET2 inhibits the proliferation and metastasis of lung adenocarcinoma cells via activation of the cGAS-STING signalling pathway","volume":"23","author":"Cheng","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0095","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.tcb.2022.06.010","article-title":"Targeting STING to promote antitumor immunity","volume":"33","author":"Chin","year":"2023","journal-title":"Trends in Cell Biology"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0100","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3389\/fonc.2020.00758","article-title":"Pharmacological STING activation is a potential alternative to overcome drug-resistance in melanoma","volume":"10","author":"Chipurupalli","year":"2020","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.111942","article-title":"GALNT6 dual regulates innate immunity STING signaling and PD-L1 expression to promote immune evasion in pancreatic ductal adenocarcinoma","volume":"134","author":"Chong","year":"2025","journal-title":"Cellular Signalling"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2022.100856","article-title":"A G-quadruplex stabilizer, CX-5461 combined with two immune checkpoint inhibitors enhances in vivo therapeutic efficacy by increasing PD-L1 expression in colorectal cancer","volume":"35","author":"Chung","year":"2023","journal-title":"Neoplasia"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0115","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41573-022-00558-5","article-title":"Targeting replication stress in cancer therapy","volume":"22","author":"da Costa","year":"2023","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0120","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.semcancer.2019.08.019","article-title":"Paradoxical effects of chemotherapy on tumor relapse and metastasis promotion","volume":"60","author":"D'Alterio","year":"2020","journal-title":"Seminars in Cancer Biology"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0125","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/j.cell.2021.03.009","article-title":"Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes","volume":"184","author":"Dentro","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114902","article-title":"cGAS-STING and neurodegenerative diseases: A molecular crosstalk and therapeutic perspective","volume":"159","author":"Dhapola","year":"2025","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0135","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.celrep.2013.05.009","article-title":"The innate immune DNA sensor cGAS produces a noncanonical cyclic dinucleotide that activates human STING","volume":"3","author":"Diner","year":"2013","journal-title":"Cell Reports"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0140","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jconrel.2022.03.054","article-title":"Systemic nano-delivery of low-dose STING agonist targeted to CD103+ dendritic cells for cancer immunotherapy","volume":"345","author":"Doshi","year":"2022","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0145","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41573-024-01060-w","article-title":"DNA damage response inhibitors in cancer therapy: lessons from the past, current status and future implications","volume":"24","author":"Drew","year":"2025","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0150","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s41556-025-01627-8","article-title":"ADSL-generated fumarate binds and inhibits STING to promote tumour immune evasion","volume":"27","author":"Duan","year":"2025","journal-title":"Nature Cell Biology"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0155","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1016\/j.molcel.2023.09.007","article-title":"Targeting LYPLAL1-mediated cGAS depalmitoylation enhances the response to anti-tumor immunotherapy","volume":"83","author":"Fan","year":"2023","journal-title":"Molecular Cell"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0160","article-title":"IDI1 inhibits the cGAS-Sting signaling pathway in hepatocellular carcinoma","volume":"10","author":"Fu","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0165","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.cell.2013.04.046","article-title":"Cyclic [G(2\u20195\u2019)pA(3',5')p] is the metazoan second messenger produced by DNA-activated cyclic GMP-AMP synthase","volume":"153","author":"Gao","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0170","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adv0766","article-title":"Targeting SIRT2 induces MLH1 deficiency and boosts antitumor immunity in preclinical colorectal cancer models","volume":"17","author":"Gao","year":"2025","journal-title":"Science Translational Medicine"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202205241","article-title":"Encapsulation of platinum prodrugs into PC7A polymeric nanoparticles combined with immune checkpoint inhibitors for therapeutically enhanced multimodal chemotherapy and immunotherapy by activation of the STING pathway","volume":"10","author":"Gao","year":"2023","journal-title":"Advanced Science"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0180","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.792","article-title":"LncRNA PCAT1 activates SOX2 and suppresses radioimmune responses via regulating cGAS\/STING signalling in non-small cell lung cancer","volume":"12","author":"Gao","year":"2022","journal-title":"Clinical and Translational Medicine"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0185","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1007\/s12033-024-01194-7","article-title":"GNB4 silencing promotes pyroptosis to inhibit the development of glioma by activating cGAS-STING pathway","volume":"67","author":"Gao","year":"2025","journal-title":"Molecular Biotechnology"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.753472","article-title":"Pharmacological activation of cGAS for cancer immunotherapy","volume":"12","author":"Garland","year":"2021","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0195","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ccell.2021.01.003","article-title":"Mutant p53 suppresses innate immune signaling to promote tumorigenesis","volume":"39","author":"Ghosh","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0200","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ncb3586","article-title":"Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence","volume":"19","author":"Gl\u00fcck","year":"2017","journal-title":"Nature Cell Biology"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0205","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41580-019-0159-6","article-title":"The diverse roles of DNA methylation in mammalian development and disease","volume":"20","author":"Greenberg","year":"2019","journal-title":"Nature Reviews. Molecular Cell Biology"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0210","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41568-022-00535-5","article-title":"Targeting DNA damage response pathways in cancer","volume":"23","author":"Groelly","year":"2023","journal-title":"Nature Reviews. Cancer"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0215","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202303517","article-title":"Tumor vascular destruction and cGAS-STING activation induced by single drug-loaded nano-micelles for multiple synergistic therapies of cancer","volume":"19","author":"Gu","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0220","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.tips.2022.08.006","article-title":"Nanodelivery of cGAS-STING activators for tumor immunotherapy","volume":"43","author":"Guo","year":"2022","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217946","article-title":"Inhibition of KAT6A enhances immunotherapy efficacy in colorectal cancer by activating interferon response","volume":"631","author":"Han","year":"2025","journal-title":"Cancer Letters"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0230","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1038\/s12276-024-01326-8","article-title":"SMYD family in cancer: epigenetic regulation and molecular mechanisms of cancer proliferation, metastasis, and drug resistance","volume":"56","author":"Han","year":"2024","journal-title":"Experimental & Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0235","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41571-023-00852-0","article-title":"BRAF - a tumour-agnostic drug target with lineage-specific dependencies","volume":"21","author":"Hanrahan","year":"2024","journal-title":"Nature Reviews. Clinical Oncology"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0240","doi-asserted-by":"crossref","DOI":"10.1021\/acsnano.2c11764","article-title":"Sensitizing tumors to immune checkpoint blockage via STING agonists delivered by tumor-penetrating neutrophil cytopharmaceuticals","author":"Hao","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0245","article-title":"Metal-phenolic nanocloaks on cancer cells potentiate STING pathway activation for synergistic cancer immunotherapy","volume":"63","author":"He","year":"2024","journal-title":"Angewandte Chemie (International Ed. in English)"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0250","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202308009","article-title":"RECQL4 inhibits radiation-induced tumor immune awakening via suppressing the cGAS-STING pathway in hepatocellular carcinoma","volume":"11","author":"Hong","year":"2024","journal-title":"Advanced Science"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0255","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41580-020-0244-x","article-title":"Molecular mechanisms and cellular functions of cGAS-STING signalling","volume":"21","author":"Hopfner","year":"2020","journal-title":"Nature Reviews. Molecular Cell Biology"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2023.149388","article-title":"TTK inhibition activates STING signal and promotes anti-PD1 immunotherapy in breast cancer","volume":"694","author":"Hu","year":"2024","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0265","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1158\/1535-7163.MCT-21-0780","article-title":"Pharmacologic activation of STING in the bladder induces potent antitumor immunity in non-muscle invasive murine bladder cancer","volume":"21","author":"Huang","year":"2022","journal-title":"Molecular Cancer Therapeutics"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0270","first-page":"2055","article-title":"Disulfiram combined with chemoimmunotherapy potentiates pancreatic cancer treatment efficacy through the activation of cGAS-STING signaling pathway via suppressing PARP1 expression","volume":"13","author":"Huang","year":"2023","journal-title":"American Journal of Cancer Research"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0275","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1038\/s41467-023-40952-0","article-title":"DNAJA2 deficiency activates cGAS-STING pathway via the induction of aberrant mitosis and chromosome instability","volume":"14","author":"Huang","year":"2023","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0280","article-title":"Mn-Anti-CTLA4-CREKA-sericin nanotheragnostics for enhanced magnetic resonance imaging and tumor immunotherapy","volume":"20","author":"Huang","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0285","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature07317","article-title":"STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling","volume":"455","author":"Ishikawa","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0290","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1158\/2326-6066.CIR-22-0260","article-title":"CD73 inhibits cGAS-STING and cooperates with CD39 to promote pancreatic cancer","volume":"11","author":"Jacoberger-Foissac","year":"2023","journal-title":"Cancer Immunology Research"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0295","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00781-25","article-title":"Microvesicle-transferred mitochondria trigger cGAS-STING and reprogram metabolism of macrophages in sepsis","volume":"13","author":"Ji","year":"2025","journal-title":"Microbiology Spectrum"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0300","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.chom.2023.04.010","article-title":"Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer","volume":"31","author":"Jiang","year":"2023","journal-title":"Cell Host & Microbe"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0305","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13578-021-00586-5","article-title":"RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS\/STING signaling pathway in lung adenocarcinoma","volume":"11","author":"Jiang","year":"2021","journal-title":"Cell & Bioscience"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0310","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41573-022-00615-z","article-title":"Rational combinations of targeted cancer therapies: background, advances and challenges","volume":"22","author":"Jin","year":"2023","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0315","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.neuroscience.2025.04.001","article-title":"Unraveling the cGAS-STING pathway in Alzheimer's disease: A new Frontier in neuroinflammation and therapeutic strategies","volume":"573","author":"Kaur","year":"2025","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0320","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1158\/2326-6066.CIR-23-0902","article-title":"Cannabidiol enhances Atezolizumab efficacy by upregulating PD-L1 expression via the cGAS-STING pathway in triple-negative breast cancer cells","volume":"12","author":"Kim","year":"2024","journal-title":"Cancer Immunology Research"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0325","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz5683","article-title":"PRMT5 control of cGAS\/STING and NLRC5 pathways defines melanoma response to antitumor immunity","volume":"12","author":"Kim","year":"2020","journal-title":"Science Translational Medicine"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0330","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.3390\/cancers14194847","article-title":"Midostaurin modulates tumor microenvironment and enhances efficacy of anti-PD-1 against colon cancer","volume":"14","author":"Lai","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0335","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002195","article-title":"STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer","volume":"9","author":"Lee","year":"2021","journal-title":"Journal for Immunotherapy of Cancer"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217991","article-title":"Inhibition of CPT1A activates the cGAS\/STING pathway to enhance neutrophil-mediated tumor abrogation in triple-negative breast cancer","volume":"633","author":"Li","year":"2025","journal-title":"Cancer Letters"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0345","doi-asserted-by":"crossref","DOI":"10.1080\/01443615.2024.2361849","article-title":"Knockdown of S100A2 inhibits the aggressiveness of endometrial cancer by activating STING pathway","volume":"44","author":"Li","year":"2024","journal-title":"Journal of Obstetrics and Gynaecology"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115982","article-title":"Small molecules targeting selected histone methyltransferases (HMTs) for cancer treatment: Current progress and novel strategies","volume":"264","author":"Li","year":"2024","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0355","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1186\/s12951-023-02132-6","article-title":"Tumor microenvironment-responsive DNA-based nanomedicine triggers innate sensing for enhanced immunotherapy","volume":"21","author":"Li","year":"2023","journal-title":"Journal of Nanobiotechnology"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0360","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.3390\/cancers13133204","article-title":"Depletion of DNA polymerase theta inhibits tumor growth and promotes genome instability through the cGAS-STING-ISG pathway in esophageal squamous cell carcinoma","volume":"13","author":"Li","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2025.108611","article-title":"Targeting IDH2 promotes antitumor immunity through epigenetic activation of cGAS-STING pathway","volume":"205","author":"Li","year":"2025","journal-title":"Lung Cancer"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0370","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/s41467-023-36523-y","article-title":"TRIM21 inhibits irradiation-induced mitochondrial DNA release and impairs antitumour immunity in nasopharyngeal carcinoma tumour models","volume":"14","author":"Li","year":"2023","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0375","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004006","article-title":"Hyperbaric oxygen facilitates teniposide-induced cGAS-STING activation to enhance the antitumor efficacy of PD-1 antibody in HCC","volume":"10","author":"Li","year":"2022","journal-title":"Journal for Immunotherapy of Cancer"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0380","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1186\/s12967-023-04743-x","article-title":"Silencing HOXC13 exerts anti-prostate cancer effects by inducing DNA damage and activating cGAS\/STING\/IRF3 pathway","volume":"21","author":"Li","year":"2023","journal-title":"Journal of Translational Medicine"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0385","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12916-024-03375-2","article-title":"PREX2 contributes to radiation resistance by inhibiting radiotherapy-induced tumor immunogenicity via cGAS\/STING\/IFNs pathway in colorectal cancer","volume":"22","author":"Li","year":"2024","journal-title":"BMC Medicine"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0390","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1158\/2326-6066.CIR-23-1078","article-title":"The exonuclease TREX1 constitutes an innate immune checkpoint limiting cGAS\/STING-mediated antitumor immunity","volume":"12","author":"Lim","year":"2024","journal-title":"Cancer Immunology Research"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0395","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1158\/2326-6066.CIR-21-0754","article-title":"The SETDB1-TRIM28 complex suppresses antitumor immunity","volume":"9","author":"Lin","year":"2021","journal-title":"Cancer Immunology Research"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0400","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbrc.2023.09.073","article-title":"DTX3L mediated ubiquitination of cGAS suppresses antitumor immunity in pancreatic cancer","volume":"681","author":"Lin","year":"2023","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116912","article-title":"Discovery of CN0 as a novel proteolysis-targeting chimera (PROTAC) degrader of PARP1 that can activate the cGAS\/STING immunity pathway combined with daunorubicin","volume":"70","author":"Lin","year":"2022","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0410","article-title":"Targeting tumor-associated macrophages with STING agonism improves the antitumor efficacy of osimertinib in a mouse model of EGFR-mutant lung cancer","volume":"14","author":"Lin","year":"2023","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105997","article-title":"Clinical experience with CTLA-4 blockade for cancer immunotherapy: From the monospecific monoclonal antibody ipilimumab to probodies and bispecific molecules targeting the tumor microenvironment","volume":"175","author":"Lisi","year":"2022","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0420","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1038\/s41467-023-38443-3","article-title":"PRMT1 mediated methylation of cGAS suppresses anti-tumor immunity","volume":"14","author":"Liu","year":"2023","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0425","doi-asserted-by":"crossref","first-page":"622","DOI":"10.7150\/thno.88759","article-title":"Pharmacological inhibition of MYC to mitigate chemoresistance in preclinical models of squamous cell carcinoma","volume":"14","author":"Liu","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0430","doi-asserted-by":"crossref","first-page":"13730","DOI":"10.1073\/pnas.1919690117","article-title":"Selective reactivation of STING signaling to target Merkel cell carcinoma","volume":"117","author":"Liu","year":"2020","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0435","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1038\/s41467-023-39920-5","article-title":"ARIH1 activates STING-mediated T-cell activation and sensitizes tumors to immune checkpoint blockade","volume":"14","author":"Liu","year":"2023","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0440","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1158\/0008-5472.CAN-24-2038","article-title":"Hypoxia induces immunosuppression by silencing STING in cancer","volume":"85","author":"Lu","year":"2025","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0445","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s40164-024-00546-y","article-title":"Overexpression of ESYT3 improves radioimmune responses through activating cGAS-STING pathway in lung adenocarcinoma","volume":"13","author":"Luo","year":"2024","journal-title":"Experimental Hematology & Oncology"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0450","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1038\/s41556-024-01473-0","article-title":"mTORC2-driven chromatin cGAS mediates chemoresistance through epigenetic reprogramming in colorectal cancer","volume":"26","author":"Lv","year":"2024","journal-title":"Nature Cell Biology"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0455","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41467-023-43743-9","article-title":"TET2-mediated tumor cGAS triggers endothelial STING activation to regulate vasculature remodeling and anti-tumor immunity in liver cancer","volume":"15","author":"Lv","year":"2024","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0460","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3389\/fgene.2020.00250","article-title":"LncRNA NEAT1 interacted with DNMT1 to regulate malignant phenotype of cancer cell and cytotoxic T cell infiltration via epigenetic inhibition of p53, cGAS, and STING in lung cancer","volume":"11","author":"Ma","year":"2020","journal-title":"Frontiers in Genetics"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0465","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.7150\/thno.73152","article-title":"Docetaxel remodels prostate cancer immune microenvironment and enhances checkpoint inhibitor-based immunotherapy","volume":"12","author":"Ma","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0470","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1182\/blood.2023019782","article-title":"Inhibition of PLK4 remodels histone methylation and activates the immune response via the cGAS-STING pathway in TP53-mutated AML","volume":"142","author":"Man","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0475","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41568-020-00302-4","article-title":"Non-genetic mechanisms of therapeutic resistance in cancer","volume":"20","author":"Marine","year":"2020","journal-title":"Nature Reviews. Cancer"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0480","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1038\/s41598-024-54732-3","article-title":"Aryl hydrocarbon receptor suppresses STING-mediated type I IFN expression in triple-negative breast cancer","volume":"14","author":"Martin","year":"2024","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0485","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cell.2021.12.005","article-title":"EMSY inhibits homologous recombination repair and the interferon response, promoting lung cancer immune evasion","volume":"185","author":"Marzio","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0490","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1038\/s41467-022-29335-z","article-title":"Modification of BRCA1-associated breast cancer risk by HMMR overexpression","volume":"13","author":"Mateo","year":"2022","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0495","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1158\/0008-5472.CAN-19-2330","article-title":"Inhibition of haspin kinase promotes cell-intrinsic and extrinsic antitumor activity","volume":"80","author":"Melms","year":"2020","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0500","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1016\/j.molcel.2021.07.040","article-title":"Induced phase separation of mutant NF2 imprisons the cGAS-STING machinery to abrogate antitumor immunity","volume":"81","author":"Meng","year":"2021","journal-title":"Molecular Cell"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0505","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1158\/0008-5472.CAN-22-3382","article-title":"PP2Ac deficiency enhances tumor immunogenicity by activating STING-Type I interferon signaling in glioblastoma","volume":"83","author":"Mondal","year":"2023","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0510","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s43018-021-00185-w","article-title":"EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer","volume":"2","author":"Morel","year":"2021","journal-title":"Nature Cancer"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0515","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002852","article-title":"STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation","volume":"9","author":"Nakamura","year":"2021","journal-title":"Journal for Immunotherapy of Cancer"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2025.108834","article-title":"Understanding the regulatory landscape of protein phosphatase 2A (PP2A): Pharmacological modulators and potential therapeutics","volume":"269","author":"Neale","year":"2025","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0525","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.tcb.2017.05.001","article-title":"Serine and functional metabolites in cancer","volume":"27","author":"Newman","year":"2017","journal-title":"Trends in Cell Biology"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115733","article-title":"Targeting WEE1 in tumor-associated dendritic cells potentiates antitumor immunity via the cGAS\/STING pathway","volume":"44","author":"Ng","year":"2025","journal-title":"Cell Reports"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0535","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s13046-025-03513-5","article-title":"TRIM6 ablation reverses ICB resistance in MSS gastric cancer by unleashing cGAS-STING-dependent antitumor immunity","volume":"44","author":"Niu","year":"2025","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0540","doi-asserted-by":"crossref","DOI":"10.1172\/JCI165934","article-title":"POLQ inhibition elicits an immune response in homologous recombination-deficient pancreatic adenocarcinoma via cGAS\/STING signaling","volume":"133","author":"Oh","year":"2023","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0545","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1158\/1535-7163.MCT-22-0369","article-title":"BET inhibition sensitizes immunologically cold Rb-deficient prostate cancer to immune checkpoint blockade","volume":"22","author":"Olson","year":"2023","journal-title":"Molecular Cancer Therapeutics"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0550","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.694","article-title":"Mechanisms of resistance to tyrosine kinase inhibitor-targeted therapy and overcoming strategies","volume":"5","author":"Ou","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0555","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1039\/D2BM02140D","article-title":"A manganese-phenolic network platform amplifying STING activation to potentiate MRI guided cancer chemo-\/chemodynamic\/immune therapy","volume":"11","author":"Pang","year":"2023","journal-title":"Biomaterials Science"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0560","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41523-022-00471-5","article-title":"STING agonism enhances anti-tumor immune responses and therapeutic efficacy of PARP inhibition in BRCA-associated breast cancer","volume":"8","author":"Pantelidou","year":"2022","journal-title":"npj Breast Cancer"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0565","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.887649","article-title":"Biodegradable nanoparticles induce cGAS\/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy","volume":"13","author":"Podojil","year":"2022","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0570","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12967-024-05023-y","article-title":"Silencing PinX1 enhances radiosensitivity and antitumor-immunity of radiotherapy in non-small cell lung cancer","volume":"22","author":"Qiu","year":"2024","journal-title":"Journal of Translational Medicine"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0575","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13024-025-00815-2","article-title":"The neuroimmune nexus: unraveling the role of the mtDNA-cGAS-STING signal pathway in Alzheimer's disease","volume":"20","author":"Quan","year":"2025","journal-title":"Molecular Neurodegeneration"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0580","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005026","article-title":"PP4 inhibition sensitizes ovarian cancer to NK cell-mediated cytotoxicity via STAT1 activation and inflammatory signaling","volume":"10","author":"Raja","year":"2022","journal-title":"Journal for Immunotherapy of Cancer"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115441","article-title":"Lactylation orchestrates ubiquitin-independent degradation of cGAS and promotes tumor growth","volume":"44","author":"Rao","year":"2025","journal-title":"Cell Reports"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0590","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1158\/0008-5472.CAN-23-1788","article-title":"Serine depletion promotes antitumor immunity by activating mitochondrial DNA-mediated cGAS-STING signaling","volume":"84","author":"Saha","year":"2024","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0595","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/s43018-022-00468-w","article-title":"The cGAS-STING pathway and cancer","volume":"3","author":"Samson","year":"2022","journal-title":"Nature Cancer"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2019.100646","article-title":"The emergence of drug resistance to targeted cancer therapies: Clinical evidence","volume":"47","author":"Sarmento-Ribeiro","year":"2019","journal-title":"Drug Resistance Updates"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0605","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.micpath.2019.05.004","article-title":"cGAS-STING responses are dampened in high-risk HPV type 16 positive head and neck squamous cell carcinoma cells","volume":"132","author":"Shaikh","year":"2019","journal-title":"Microbial Pathogenesis"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0610","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006170","article-title":"Cancer cell genotype associated tumor immune microenvironment exhibits differential response to therapeutic STING pathway activation in high-grade serous ovarian cancer","volume":"11","author":"Shakfa","year":"2023","journal-title":"Journal for Immunotherapy of Cancer"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0615","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202203523","article-title":"Systemic delivery of mPEG-masked trispecific T-cell nanoengagers in synergy with STING agonists overcomes immunotherapy resistance in TNBC and generates a vaccination effect","volume":"9","author":"Shen","year":"2022","journal-title":"Advanced Science"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0620","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41581-022-00589-6","article-title":"Role of the cGAS-STING pathway in systemic and organ-specific diseases","volume":"18","author":"Skopelja-Gardner","year":"2022","journal-title":"Nature Reviews. Nephrology"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0625","first-page":"155","article-title":"Targeted cancer therapies","volume":"103","author":"Smith","year":"2021","journal-title":"American Family Physician"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0630","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1007\/s10495-024-02008-6","article-title":"Deubiquitinating enzyme USP28 inhibitor AZ1 alone and in combination with cisplatin for the treatment of non-small cell lung cancer","volume":"29","author":"Song","year":"2024","journal-title":"Apoptosis"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0635","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.tips.2025.01.006","article-title":"Leveraging non-enzymatic functions of LSD1 for novel therapeutics","volume":"46","author":"Song","year":"2025","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0640","article-title":"Nanoscale metal-organic frameworks-mediated degradation of mutant p53 proteins and activation of cGAS-STING pathway for enhanced cancer immunotherapy","volume":"11","author":"Sun","year":"2024","journal-title":"Advancement of Science"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0645","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1126\/science.1232458","article-title":"Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway","volume":"339","author":"Sun","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0650","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1598","article-title":"Targeting KDM4 family epigenetically triggers antitumour immunity via enhancing tumour-intrinsic innate sensing and immunogenicity","volume":"14","author":"Sun","year":"2024","journal-title":"Clinical and Translational Medicine"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0655","article-title":"DNA2 protein destruction dictates DNA hyperexcision, cGAS-STING activation, and innate immune response in CDK12-deregulated cancers","volume":"122","author":"Sun","year":"2025","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107314","article-title":"Tetrandrine activates STING\/TBK1\/IRF3 pathway to potentiate anti-PD-1 immunotherapy efficacy in non-small cell lung cancer","volume":"207","author":"Tan","year":"2024","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0665","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.1158\/1078-0432.CCR-17-2807","article-title":"Mitigating SOX2-potentiated immune escape of head and neck squamous cell carcinoma with a STING-inducing nanosatellite vaccine","volume":"24","author":"Tan","year":"2018","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0670","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ade6624","article-title":"SMYD2 inhibition-mediated hypomethylation of Ku70 contributes to impaired nonhomologous end joining repair and antitumor immunity","volume":"9","author":"Tang","year":"2023","journal-title":"Science Advances"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0675","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41401-025-01639-y","article-title":"DNMT inhibition epigenetically restores the cGAS-STING pathway and activates RIG-I\/MDA5-MAVS to enhance antitumor immunity","volume":"47","author":"Tu","year":"2026","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0680","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41573-019-0043-2","article-title":"Pharmacological modulation of nucleic acid sensors - therapeutic potential and persisting obstacles","volume":"18","author":"Vanpouille-Box","year":"2019","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0685","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41419-022-04701-3","article-title":"Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in trans","volume":"13","author":"Vicencio","year":"2022","journal-title":"Cell Death & Disease"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0690","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mattod.2022.11.008","article-title":"Overcoming pancreatic cancer immune resistance by codelivery of CCR2 antagonist using a STING-activating gemcitabine-based nanocarrier","volume":"62","author":"Wan","year":"2023","journal-title":"Materials Today"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0695","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1158\/0008-5472.CAN-23-0394","article-title":"Fimepinostat impairs NF-\u03baB and PI3K\/AKT signaling and enhances gemcitabine efficacy in H3K27M-mutated diffuse intrinsic pontine glioma","volume":"84","author":"Wang","year":"2024","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0700","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102691","article-title":"cGAS-STING targeting offers novel therapeutic opportunities in neurological diseases","volume":"105","author":"Wang","year":"2025","journal-title":"Ageing Research Reviews"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0705","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41419-025-07960-y","article-title":"Tumor-derived PRMT1 suppresses macrophage antitumor activity by inhibiting cGAS\/STING signaling in gastric cancer cells","volume":"16","author":"Wang","year":"2025","journal-title":"Cell Death & Disease"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0710","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.146268","article-title":"TRIM27 promotes ovarian cancer progression through destabilizing AMPK and thus inactivating the cGAS\/STING signaling pathway","volume":"321","author":"Wang","year":"2025","journal-title":"International Journal of Biological Macromolecules"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0715","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202216235","article-title":"Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance","volume":"15","author":"Wang","year":"2023","journal-title":"EMBO Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0720","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007035","article-title":"Inhibition of tumor intrinsic BANF1 activates antitumor immune responses via cGAS-STING and enhances the efficacy of PD-1 blockade","volume":"11","author":"Wang","year":"2023","journal-title":"Journal for Immunotherapy of Cancer"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0725","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1038\/s41467-022-30568-1","article-title":"STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer","volume":"13","author":"Wang","year":"2022","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0730","article-title":"Targeting DNA damage and repair machinery via delivering WEE1 inhibitor and platinum (IV) prodrugs to stimulate STING pathway for maximizing chemo-immunotherapy in bladder cancer","volume":"36","author":"Wang","year":"2024","journal-title":"Advanced Materials"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0735","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117905","article-title":"Pharmacologically targeting protein lactylation to overcome cancer drug resistance","volume":"296","author":"Wang","year":"2025","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0740","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41392-023-01720-0","article-title":"Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107137","article-title":"cGAS-STING targeting offers a novel therapeutic paradigm in cardiovascular diseases","volume":"211","author":"Wang","year":"2025","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0750","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1007\/s00204-025-04150-9","article-title":"Interplay of cGAS-STING and ferroptosis: crosstalk, molecular mechanisms, and therapeutic prospects","volume":"99","author":"Wang","year":"2025","journal-title":"Archives of Toxicology"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0755","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00204-025-04206-w","article-title":"cGAS-STING and autophagy: crosstalk, molecular mechanisms, and targeted therapy","volume":"100","author":"Wang","year":"2026","journal-title":"Archives of Toxicology"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0760","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13062-025-00611-4","article-title":"cGAS-STING targeting offers therapy choice in lung diseases","volume":"20","author":"Wang","year":"2025","journal-title":"Biology Direct"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0765","article-title":"The activation of cGAS-STING pathway offers novel therapeutic opportunities in cancers","volume":"16","author":"Wang","year":"2025","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0770","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1158\/0008-5472.CAN-20-3738","article-title":"SHP2-mediated inhibition of DNA repair contributes to cGAS-STING activation and chemotherapeutic sensitivity in colon cancer","volume":"81","author":"Wei","year":"2021","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0775","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1126\/science.1073096","article-title":"Cancer. Addiction to oncogenes--the Achilles heal of cancer","volume":"297","author":"Weinstein","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0780","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1126\/science.1229963","article-title":"Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA","volume":"339","author":"Wu","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0785","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2006134","article-title":"KDM5 histone demethylases repress immune response via suppression of STING","volume":"16","author":"Wu","year":"2018","journal-title":"PLoS Biology"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0790","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1111\/cas.15108","article-title":"WEE1 inhibitor and ataxia telangiectasia and RAD3-related inhibitor trigger stimulator of interferon gene-dependent immune response and enhance tumor treatment efficacy through programmed death-ligand 1 blockade","volume":"112","author":"Wu","year":"2021","journal-title":"Cancer Science"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0795","doi-asserted-by":"crossref","first-page":"6747","DOI":"10.1158\/0008-5472.CAN-16-1404","article-title":"Recurrent loss of STING signaling in melanoma correlates with susceptibility to viral oncolysis","volume":"76","author":"Xia","year":"2016","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0800","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adi2465","article-title":"Inhibition of ACLY overcomes cancer immunotherapy resistance via polyunsaturated fatty acids peroxidation and cGAS-STING activation","volume":"9","author":"Xiang","year":"2023","journal-title":"Science Advances"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0805","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70006","article-title":"CKIP-1 silencing suppresses OSCC via mitochondrial homeostasis-associated TFAM\/cGAS-STING signalling axis","volume":"28","author":"Xie","year":"2024","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0810","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1186\/s12885-024-12296-5","article-title":"Knockdown of CENPM activates cGAS-STING pathway to inhibit ovarian cancer by promoting pyroptosis","volume":"24","author":"Xie","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0815","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41419-024-06493-0","article-title":"Targeting AXL induces tumor-intrinsic immunogenic response in tyrosine kinase inhibitor-resistant liver cancer","volume":"15","author":"Xie","year":"2024","journal-title":"Cell Death & Disease"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0820","article-title":"Precisely activating cGAS-STING pathway with a novel peptide-based nanoagonist to potentiate immune checkpoint blockade cancer immunotherapy","volume":"11","author":"Xing","year":"2024","journal-title":"Advancement of Science"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0825","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202350386","article-title":"cGAS-STING signaling in cell death: Mechanisms of action and implications in pathologies","volume":"53","author":"Xu","year":"2023","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0830","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111628","article-title":"Enhanced NK cell activation via eEF2K-mediated potentiation of the cGAS-STING pathway in hepatocellular carcinoma","volume":"129","author":"Xu","year":"2024","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0835","article-title":"Targeting cGAS-STING: modulating the immune landscape of hepatic diseases","volume":"16","author":"Xue","year":"2025","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0840","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1158\/0008-5472.CAN-20-2370","article-title":"MEK inhibition remodels the immune landscape of mutant KRAS tumors to overcome resistance to PARP and immune checkpoint inhibitors","volume":"81","author":"Yang","year":"2021","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0845","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.7150\/ijbs.79654","article-title":"Loss of HRD functional phenotype impedes immunotherapy and can be reversed by HDAC inhibitor in ovarian cancer","volume":"19","author":"Yang","year":"2023","journal-title":"International Journal of Biological Sciences"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0850","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.875318","article-title":"Novel insights on lipid metabolism alterations in drug resistance in cancer","volume":"10","author":"Yang","year":"2022","journal-title":"Frontiers in Cell and Development Biology"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0855","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103877","article-title":"Intersection of immune signaling and cell death: The bidirectional regulatory mechanism of STING pathway and Ferroptosis","volume":"24","author":"Yao","year":"2025","journal-title":"Autoimmunity Reviews"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0860","doi-asserted-by":"crossref","first-page":"20793","DOI":"10.18632\/aging.203475","article-title":"Stimulator of interferon response cGAMP interactor overcomes ERBB2-mediated apatinib resistance in head and neck squamous cell carcinoma","volume":"13","author":"Ye","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0865","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12943-021-01489-2","article-title":"Combination strategies with PD-1\/PD-L1 blockade: current advances and future directions","volume":"21","author":"Yi","year":"2022","journal-title":"Molecular Cancer"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0870","doi-asserted-by":"crossref","first-page":"607","DOI":"10.55730\/1300-0144.5828","article-title":"STING activation increases the efficiency of temozolomide in PTEN harbouring glioblastoma cells","volume":"54","author":"Yildirim","year":"2024","journal-title":"Turkish Journal of Medical Sciences"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0875","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202206737","article-title":"Raddeanin A enhances mitochondrial DNA-cGAS\/STING axis-mediated antitumor immunity by targeting transactive responsive DNA-binding protein 43","volume":"10","author":"Yin","year":"2023","journal-title":"Advanced Science"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0880","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1080\/15384101.2022.2029996","article-title":"STING agonist enhances the efficacy of programmed death-ligand 1 monoclonal antibody in breast cancer immunotherapy by activating the interferon-\u03b2 signalling pathway","volume":"21","author":"Yin","year":"2022","journal-title":"Cell Cycle"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0885","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154669","article-title":"Label-free-based quantitative proteomic analysis of the inhibition of cisplatin-resistant ovarian cancer cell proliferation by cucurbitacin B","volume":"111","author":"Yin","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0890","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1158\/0008-5472.CAN-22-0770","article-title":"MET-induced CD73 restrains STING-mediated immunogenicity of EGFR-mutant lung cancer","volume":"82","author":"Yoshida","year":"2022","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0895","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.semcancer.2024.08.007","article-title":"cGAS\/STING signalling pathway in senescence and oncogenesis","volume":"106-107","author":"Yu","year":"2024","journal-title":"Seminars in Cancer Biology"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0900","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1146\/annurev-immunol-101721-032910","article-title":"Regulation of the cGAS-STING pathway","volume":"43","author":"Zhang","year":"2025","journal-title":"Annual Review of Immunology"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0905","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s13046-021-01987-7","article-title":"Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer","volume":"40","author":"Zhang","year":"2021","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0910","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41416-024-02742-3","article-title":"Disruption of DNA-PKcs-mediated cGAS retention on damaged chromatin potentiates DNA damage-inducing agent-induced anti-multiple myeloma activity","volume":"131","author":"Zhang","year":"2024","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0915","article-title":"Inactivated cGAS-STING signaling facilitates endocrine resistance by forming a positive feedback loop with AKT kinase in ER+HER2- breast cancer","volume":"11","author":"Zhang","year":"2024","journal-title":"Advancement of Science"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0920","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.3390\/cancers15061802","article-title":"Inhibition of IDH3\u03b1 enhanced the efficacy of chemoimmunotherapy by regulating acidic tumor microenvironments","volume":"15","author":"Zhang","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0925","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bioactmat.2025.07.040","article-title":"Metabolic modulation-driven self-reinforcing pyroptosis-STING nanoadjuvant for potentiated metalloimmunotherapy","volume":"53","author":"Zhang","year":"2025","journal-title":"Bioactive Materials"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0930","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/s11427-024-2808-3","article-title":"cGAS-STING: mechanisms and therapeutic opportunities","volume":"68","author":"Zhang","year":"2025","journal-title":"Science China. Life Sciences"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0935","article-title":"Combining cisplatin and a STING agonist into one molecule for metalloimmunotherapy of cancer","volume":"11","author":"Zhang","year":"2024","journal-title":"National Science Review"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0940","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1016\/j.molcel.2021.02.038","article-title":"Targeting KDM4A epigenetically activates tumor-cell-intrinsic immunity by inducing DNA replication stress","volume":"81","author":"Zhang","year":"2021","journal-title":"Molecular Cell"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0945","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.molcel.2013.05.022","article-title":"Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING","volume":"51","author":"Zhang","year":"2013","journal-title":"Molecular Cell"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0950","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41577-024-01112-7","article-title":"Regulation of cGAS-STING signalling and its diversity of cellular outcomes","volume":"25","author":"Zhang","year":"2025","journal-title":"Nature Reviews. Immunology"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0955","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41392-022-01252-z","article-title":"Multifaceted functions of STING in human health and disease: From molecular mechanism to targeted strategy","volume":"7","author":"Zhang","year":"2022","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0960","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/03008916211026019","article-title":"Hypoxia-induced RNASEH2A limits activation of cGAS-STING signaling in HCC and predicts poor prognosis","volume":"108","author":"Zhao","year":"2022","journal-title":"Tumori"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0965","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103823","article-title":"Rebalancing redox homeostasis: A pivotal regulator of the cGAS-STING pathway in autoimmune diseases","volume":"24","author":"Zhao","year":"2025","journal-title":"Autoimmunity Reviews"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0970","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1016\/j.apsb.2022.02.021","article-title":"Lenvatinib- and vadimezan-loaded synthetic high-density lipoprotein for combinational immunochemotherapy of metastatic triple-negative breast cancer","volume":"12","author":"Zheng","year":"2022","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0975","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.immuni.2008.09.003","article-title":"The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation","volume":"29","author":"Zhong","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0980","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cytogfr.2025.07.004","article-title":"Targeting cGAS-STING signaling and cell death modes in cancer and autoimmune diseases","volume":"85","author":"Zhou","year":"2025","journal-title":"Cytokine & Growth Factor Reviews"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0985","doi-asserted-by":"crossref","DOI":"10.1093\/nsr\/nwad214","article-title":"STING agonist-boosted mRNA immunization via intelligent design of nanovaccines for enhancing cancer immunotherapy","volume":"10","author":"Zhou","year":"2023","journal-title":"National Science Review"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0990","doi-asserted-by":"crossref","first-page":"10350","DOI":"10.1021\/acs.nanolett.3c02941","article-title":"Manganese-Enriched Zinc Peroxide Functional Nanoparticles for Potentiating Cancer Immunotherapy","volume":"23","author":"Zhou","year":"2023","journal-title":"Nano Letters"},{"key":"10.1016\/j.pharmthera.2026.108991_bb0995","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114679","article-title":"Therapeutic targeting the cGAS-STING pathway associated with protein and gene: An emerging and promising novel strategy for aging-related neurodegenerative disease","volume":"156","author":"Zhou","year":"2025","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.pharmthera.2026.108991_bb1000","article-title":"PRMT5 inhibitor synergizes with chemotherapy to induce resembling mismatch repair deficiency and enhance anti-TIGIT therapy in microsatellite-stable colorectal cancer","volume":"12","author":"Zhu","year":"2025","journal-title":"Advanced Science"},{"key":"10.1016\/j.pharmthera.2026.108991_bb1005","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41419-023-06303-z","article-title":"Novel dual inhibitors of PARP and HDAC induce intratumoral STING-mediated antitumor immunity in triple-negative breast cancer","volume":"15","author":"Zhu","year":"2024","journal-title":"Cell Death & Disease"},{"key":"10.1016\/j.pharmthera.2026.108991_bb1010","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.ijrobp.2022.12.045","article-title":"Yes-associated protein 1 inhibition induces immunogenic cell death and synergizes with radiation and PD-1 blockade","volume":"116","author":"Zhuang","year":"2023","journal-title":"International Journal of Radiation Oncology, Biology, Physics"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725826000185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725826000185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T13:37:10Z","timestamp":1771681030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725826000185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":202,"alternative-id":["S0163725826000185"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2026.108991","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological activation of cGAS-STING pathway to reverse cancer drug resistance","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2026.108991","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108991"}}